Hinge Health.
healthcare organization in San Francisco, United States
- Reports this week
- 1
- Active events
- 1
- Connections
- 53
What's happening
Active this week
Earlier this month
One to three months ago
-
IP Group listed on the London Stock Exchange, backing high-profile companies including Hysata, Hinge Health, and Oxa.Some support1 report
-
Director Kristina M. Leslie sold 1,200 shares of Class A common stock of Hinge Health on September 4, 2026.Some support1 report
-
CEO Daniel Perez framed the Cylinder deal for Hinge Health on August 12, 2026.Some support3 reports
-
Jim Cramer expressed bullish sentiment on Hinge Health stock on July 16, 2025.Some support2 reports
-
Hinge Health and Omada Health are identified as companies operating within the digital health IPO sector.Some support2 reports1 development inside
-
Market reports detail funding and M&A trends affecting companies like Hinge Health within the digital health market.Some support1 report
Gone quiet
No new reports in 90+ days-
Citigroup reaffirmed an outperform rating on Hinge Health on June 24, 2026.Some support1 report
-
Hinge Health made required disclosures via filings with the SEC on June 24, 2026.Some support1 report
-
Hinge Health disclosed financial data to the Securities and Exchange Commission.Some support1 report
-
Hinge Health disclosed chairman stock sales via required filings with the Securities & Exchange Commission on June 6, 2026.Some support3 reports
-
Progyny welcomed Hinge Health and integrated oriGIn's pelvic floor therapy into its offerings.Speculative1 report
-
Hinge Health developed healthcare software in the US, while Symbotic reported revenue growth that outpaced the broader US market.Speculative1 report
-
A price target raise for Hinge Health following the company's Q2 results and guidance, driven by the company's performance.Some support2 reports1 development inside
No events began in the chosen period. Widen it, or reset.
Around Hinge Health this week
News at the entities that move Hinge Health most-
Perez StructuralPerez is identified as a California State Senator representing Pasadena.Moves Hinge Health
-
SEC StructuralKeefe, Bruyette & Woods raised a price target while First Western Financial disclosed a CEO stock sale filing with the SEC.Moves Hinge Health
-
Morgan Stanley TransactionalBank of America lowered its target price on Coursera shares, while Morgan Stanley also set a price objective for the company.Moves Hinge Health
-
Citigroup Mentioned togetherFrontier Group trades on Nasdaq, with Susquehanna and Citigroup lifting target prices for Frontier shares.Moves Hinge Health
-
Securities and Exchange Commission StructuralW. R. Berkley Corporation filed its earnings release with the Securities and Exchange Commission on October 1, 2026.Moves Hinge Health
-
Jim Cramer Mentioned togetherJonas discussed SpaceX's launch business and Starlink's cash flow in an interview with CNBC, drawing comments from Jim Cramer.Moves Hinge Health
Connections
The 16 strongest of 53, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Perez Structural
Perez serves as the Co-Founder and CEO of Hinge Health.
-
Daniel Perez Structural
Daniel Perez is the Co-founder and current CEO of Hinge Health.
-
Gabriel Mecklenburg Structural
Gabriel Mecklenburg is a co-founder of Hinge Health and has been involved in its stock transactions.
-
SEC Structural
Hinge Health operates under the regulatory oversight and disclosure requirements mandated by the SEC.
-
Morgan Stanley Transactional
Morgan Stanley led the offering and provided analyst ratings and coverage for Hinge Health.
-
IP Group Transactional
IP Group made an investment in Hinge Health, a high-profile company.
-
Citigroup Mentioned together
Citigroup has provided and reaffirmed an outperform rating on Hinge Health shares.
-
MSK Operational
MSK and Hinge Health are companies operating in the digital health market, competing and utilizing shared focus on musculoskeletal care solutions.
Show all 16 connections
-
Securities and Exchange Commission Structural
Hinge Health is subject to formal financial disclosure and regulation by the Securities and Exchange Commission.
-
Bank of America Mentioned together
Bank of America has provided investment coverage and ratings for Hinge Health.
-
Royal Bank of Canada Mentioned together
RBC raised its price objective for Hinge Health, reflecting financial interest and valuation assessment.
-
Jim Cramer Mentioned together
Jim Cramer provides financial commentary and buy recommendations regarding Hinge Health stock.
-
MarketBeat Mentioned together
MarketBeat publishes analyst recommendations regarding Hinge Health.
-
Raymond James Financial Mentioned together
Raymond James Financial provides financial coverage and price targets for Hinge Health.
-
Truist Financial Mentioned together
Truist Financial provides financial analysis, including target price adjustments, for Hinge Health.
-
Rock Health Mentioned together
No evidence provided in the timeline to establish a relationship between Rock Health and Hinge Health.
History
Events by the month they beganSeptember 2026
3 events- Mid-cap healthcare companies, including Hinge Health and CorVel, are competing in the market.
- IP Group listed on the London Stock Exchange, backing high-profile companies including Hysata, Hinge Health, and Oxa.
- Director Kristina M. Leslie sold 1,200 shares of Class A common stock of Hinge Health on September 4, 2026.
July 2026
1 eventShow 1 earlier month
June 2026
11 events- Raymond James Financial raised its price target for Hinge Health.
- Daniel Perez was appointed Co-Founder and CEO of Hinge Health on August 6, 2025.
- Jim Cramer expressed bullish sentiment on Hinge Health stock on July 16, 2025.
- Hinge Health and Omada Health are identified as companies operating within the digital health IPO sector.
- Citigroup reaffirmed an outperform rating on Hinge Health on June 24, 2026.
- Hinge Health made required disclosures via filings with the SEC on June 24, 2026.
- Hinge Health disclosed financial data to the Securities and Exchange Commission.
- Hinge Health disclosed chairman stock sales via required filings with the Securities & Exchange Commission on June 6, 2026.
- Progyny welcomed Hinge Health and integrated oriGIn's pelvic floor therapy into its offerings.
- Hinge Health developed healthcare software in the US, while Symbotic reported revenue growth that outpaced the broader US market.
- A price target raise for Hinge Health following the company's Q2 results and guidance, driven by the company's performance.